Biological Characterization of Genetic Mechanisms in Neuropsychiatric Disorders
神经精神疾病遗传机制的生物学特征
基本信息
- 批准号:7594625
- 负责人:
- 金额:$ 75.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AKT1 geneAccountingAdultAffectAllelesAnimalsAntipsychotic AgentsAttentionAutopsyBehaviorBiologicalBiological AssayBiologyBipolar DisorderBrainBrain regionCatecholsCell Differentiation processCell LineCell modelCellsChromosome MappingClinicalCognitionCognitiveCollaborationsComplexCouplingDARPP 32DISC1 proteinDLG4 geneDNADNA biosynthesisDRD2 geneDataData SetDevelopmentDiagnosisDiseaseDopamineEmotionalEmotionsEnvironmentEquilibriumErbB4 geneEuropeEventExonsFGF20 geneFamilyFunctional disorderGene ExpressionGenerationsGenesGeneticGenetic PolymorphismGenetic VariationGenomeGenotypeHaplotypesHereditary DiseaseHippocampus (Brain)HumanImageIncidenceIndividualIndividual DifferencesInstitutesInterviewLearningLifeLinkMajor Depressive DisorderMalignant NeoplasmsMammary NeoplasmsMediatingMemoryMental disordersMethyltransferaseMissionModificationMolecularMolecular TargetMotor ActivityMusMutationNRG1 geneNeuregulin 1NeurobiologyNeuroblastomaNeuronsNeuropeptidesNeurosciencesNeurotransmittersPLAB ProteinPathogenesisPathway interactionsPatientsPatternPerformancePhenotypePlayPrefrontal CortexPreventionProcessPropertyProtein IsoformsProtein OverexpressionProteinsPsychotic DisordersRNA SplicingRegulationRelative (related person)ResearchResearch PersonnelResourcesRiskRoleSchizophreniaScientistShort-Term MemorySignal PathwaySignal TransductionSiteSpecificityStagingStimulusStressStructureSusceptibility GeneSystemTestingTherapeuticTissuesTranscriptTranscriptional RegulationTranslatingUnited States National Institutes of HealthVariantVisionWorkage groupbasebrain morphologycase controlcell typeclinical Diagnosisdopamine systemenzyme activityfetalgene environment interactiongene functiongene interactiongenetic associationgenetic varianthuman FGF20 proteinmRNA Expressionmemory recognitionmethionylmethioninemigrationmolecular pathologyneonateneurobiological mechanismneurogenesisneuroimagingneuropsychiatryneuropsychologicalneurotransmissionnovelpituitary adenylate cyclase activating polypeptidepostnatalprogramspromoterprotein expressionreceptorsynaptogenesistraittumorigenesis
项目摘要
Genes are major contributors to many psychiatric diseases, but their mechanisms of action have long seemed elusive. To date, we have evidence of association with schizophrenia in our family datasets of at least the following genes: COMT, DTNBP1, MUTED, EAA1, MRDS1, GAD1, DISC1, FEZ1, CITRON, NDE1, NRG1, PIK3d, ErbB4, DLG4, LIS1, MHTFR, DRD2, CAPON, PPP1R1B, DAARP, GRM3, CHRNA7, KCNH2, SREB2, PRODH, CAMKIIa, AKT1, FGF20, RELN1, and RCCX. Our dataset consists of individuals from over 750 families and case/control datasets of over 650. The unique aspects of our dataset, which may explain the strength of the genetic associations that have emerged, is that every subject, both cases and controls, are evaluated extensively with structured on sight interviews by the same clinicians who have worked together on this project for over ten years. As characterization of single genetic variants rapidly proceeds, research increasingly turns to dissecting gene-gene and gene-environment interactions. Our strategy for characterizing and mapping gene effects in brain with cognitive and neuroimaging assays enables us to better define intermediate phenotypes. Here we outline recent advances of linking genes to structural and functional variation in brain systems related to cognition and emotion. One study examined genotype effect of catechol-o-methyltransferase (COMT) Val158Met on corticolimbic circuitry and functional connectivity. We found that Met/Met subjects had the ability to focus attention on relevant stimuli while inhibiting interference from other stimuli. This may be of great advantage during working memory (WM) task, but may have deleterious effects in environments with multiple stimuli requiring rapid and flexible processing. Another study evaluated COMT and GRM3 and examined their combined effects on dissociable components of the WM network. We found an epistatic interaction of these genes on the engagement of prefrontal cortex. GRM3 genotype was associated with inefficiency and altered prefrontal coupling on the background of COMT Val. As we know, abnormalities in dopamine (DA) neurotransmission contribute to psychiatric disorders. It has been shown that a network of brain regions is involved in performance of declarative and recognition memory tasks and this network, hippocampus and VLPFC, is modulated by DA. Regulation of DA signaling and neurotransmission is critically affected by COMT. We examined the effect of COMT Val158Met on function and coupling during recognition memory. There is compelling evidence that DA is an important modulator of hippocampal and prefrontal cortical interaction. This suggests that individual differences in responsivity and connectivity related to genetic modulation of DA, is a mechanism accounting for some individual differences in recognition memory performance. We also examined the effects of the PACAP gene on neurobiological traits related to risk for schizophrenia (SCZ). PACAP is a neuropeptide with neurotransmission modulating activity. We found an allele is overexpressed in patients showing an association with reduced hippocampal volume and poorer memory performance. We generated mice lacking the PACAP gene and observed abnormal behaviors, like elevated locomotor activity, which were reversed by treatment with an antipsychotic. These data suggest that alterations in PACAP signaling may contribute to the pathogenesis of SCZ.
Our examination of transcripts, protein processing and expression has resulted in several findings. One study of DA- and cAMP-regulated phosphoprotein (DARPP-32) we identified a common haplotype, which predicts mRNA expression in postmortem human brain. This haplotype is associated with enhanced performance on several cognitive tests and imaging revealed an impact on neostriatal volume, activation, and functional connectivity of PFC. We use postmortem brain to focus on postnatal developmental changes. We examined COMT enzyme activity and protein expression in the PFC in 6 age groups of normals. We found a significant increase in COMT enzyme activity from neonate to adulthood which is paralleled by increases in protein expression. COMT protein expression is related to the Val158Met genotype. These increases may reflect changes in the PFC dopamine system and stresses the importance of COMT for PFC dopamine regulation during maturation. We also examined the DISC1 gene. DISC1 is the result of a balanced molecular translocation, which segregates with major mental disorders like SCZ, bipolar disorder and major depressive disorder (MDD). Our association study of DISC1 with MDD and SCZ found the risk allele, Cys704 associated with increased risk of developing MDD. Ser704Cys variation impacts brain morphology in normals and in primary neuronal culture, knockdown of cellular DISC1 protein resulted in suppression of ERK and Akt modification, whose signaling pathways are implicated in MDD. A possible biological mechanism of MDD is associated with lower biological activity on ERK signaling.
Many human genes are known to produce more than one protein isoform through various molecular events. The use of multiple DNA replication start sites (promoters) is a frequent mechanism for generation of isoforms that provide tissue/cell type specificity, developmental-stage specificity, and allows for diverse functional properties of a gene. Neuregulin 1 (Nrg1) has nine alternative promoters. Genetic variations in promoters can contribute to genetic diseases by creating entirely new transcripts from any given gene. Such mechanisms may underlie the pathogenesis of complex diseases like SCZ. Recently, altered expression of a novel isoform (type 4) in the brain has been associated with schizo-related genetic variants. We isolated and characterized NRG1 type 4 DNA from adult and fetal human brain and identified a novel splice variant. We found a NRG1 protein representing a putative type 4 proprotein which is exclusively expressed in adult and fetal brain. Nrg1 type 4 expression is higher in the fetal brain and may have an important functional role during early brain development mediated through NRG1s effects on neurogenesis, neuronal migration, cell differentiation and synapse formation, and the regulation of neurotransmitter function. The fact that expression is brain-specific may be valuable in terms of possible therapeutics of NRG1 type 4 in SCZ. Nrg1 plays an important role in oncogenesis, and is overexpressed in various cancer tissues. However, we did not detect NRG1 type 4 in breast tumor and neuroblastoma cell lines. This absence, when juxtaposed to increased NRG1 type 4 associated with risk for SCZ, may contribute to the reduced incidence of cancer in patients SCZ and their relatives. This convergent pattern suggests that genetic regulation of type 4 may have a dual effect of protecting against cancer while increasing risk for SCZ. We have shown that type 4 represents a novel, translated, developmentally regulated, brain-specific isoform. We also show that a NRG1 promoter mutation, which impacts risk, is functional and selectively affects transcriptional levels of the type 4 isoform, providing a mechanism for the functional associations. Lastly, recent identification of NRG1 receptor, ErbB4 as a candidate SCZ risk gene, suggests that other molecules in the NRG1 pathway may also be involved. It has been shown that a molecular mechanism contributing to the genetic association of NRG1 with SCZ involves altered transcriptional regulation of a novel variant of the gene. We examined ErbB4 splice variant gene expression in hippocampus and DLPFC. ErbB4 splice patterns remain unaltered in hippocampus of SCZ, however we show an increase in expression of only the splice variant containing exons 16 and 26 in DLPFC in SCZ, suggesting that an ErbB4 receptor with exons 16 and 26 domains is preferentially upregulated in the disea
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Weinberger其他文献
Daniel Weinberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Weinberger', 18)}}的其他基金
1/3-Schizophrenia Genetics and Brain Somatic Mosaicism
1/3-精神分裂症遗传学和脑体细胞镶嵌
- 批准号:
9766879 - 财政年份:2015
- 资助金额:
$ 75.45万 - 项目类别:
1/3-Schizophrenia Genetics and Brain Somatic Mosaicism
1/3-精神分裂症遗传学和脑体细胞镶嵌
- 批准号:
9056580 - 财政年份:2015
- 资助金额:
$ 75.45万 - 项目类别:
1/3-Schizophrenia Genetics and Brain Somatic Mosaicism
1/3-精神分裂症遗传学和脑体细胞镶嵌
- 批准号:
8878693 - 财政年份:2015
- 资助金额:
$ 75.45万 - 项目类别:
Analytic Strategies and Cognitive Task Design to Study Neuropsychiatric Disorder
研究神经精神疾病的分析策略和认知任务设计
- 批准号:
8342115 - 财政年份:
- 资助金额:
$ 75.45万 - 项目类别:
Biological Characterization of Genetic Mechanisms in Neuropsychiatric Disorders
神经精神疾病遗传机制的生物学特征
- 批准号:
7735222 - 财政年份:
- 资助金额:
$ 75.45万 - 项目类别:
Transgenic Mouse Model for Mental Disorders including schizophrenia
用于精神疾病(包括精神分裂症)的转基因小鼠模型
- 批准号:
7970158 - 财政年份:
- 资助金额:
$ 75.45万 - 项目类别:
Blood Genomics and Cell Model Approaches for Neuropsychiatric Disorders
神经精神疾病的血液基因组学和细胞模型方法
- 批准号:
8158149 - 财政年份:
- 资助金额:
$ 75.45万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 75.45万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 75.45万 - 项目类别: